For the latest COVID-19 Travel restrictions and recommendations please click here

Parallel trade of pharmaceuticals in the European Union has grown consistently despite numerous challenges from some of the industry’s biggest players. The principles of free movement of goods and the regional exhaustion of intellectual property rights have helped parallel traders to make millions and the European Court of Justice has consistently ruled in their favour on cases relating to trademark issues. In response, pharmaceutical companies are now looking towards other ways of addressing parallel trade.

SMi’s 5th annual Pharmaceutical Parallel Trade conference will feature a variety of informational presentations from expert speakers with differing opinions and perspectives to offer. There will be an emphasis on the importance of effective supply chain management and pricing strategy as well as insights in to the impact of direct-to-pharmacy distribution and recent competition law developments.



Conference highlights include presentations on the following topics:

  • Alternative pricing strategies in response to parallel trade
  • Solutions offered by competition law
  • Does parallel trade have a negative impact on patients?
  • The link between parallel trade and supply shortfalls
  • Trends in parallel importing and exporting throughout Europe
  • Recent competition law developments at the Member State level



View the conference programme

 Download the brochure

 Register for the event


This conference is relevant for anyone working in the following areas:

  • Pricing and reimbursement
  • Market access
  • Health technology assessment
  • Health economics
  • Government affairs 
  • Portfolio management
  • Finance
  • Health outcomes
  • Parallel trade
  • Public affairs
  • Payer relationship management
  • Corporate strategy
  • Sales and Marketing
  • Branding
  • Regulatory Affairs
  • Stakeholder management

Currently registered delegates include representatives from: 

Merck Sharp & Dohme
Novo Nordisk

Elan Pharma International Ltd
Johnson and Johnson
Abbott GmbH & Co KG


Conference programme

8:30 Registration and coffee

9:00 Chairman's opening remarks

Jim Thomson

Jim Thomson, Chair, European Alliance for Access to Safe Medicines

9:10 From import to export: Parallel trade in the UK

Phill O'Neill

Phill O'Neill, Consultant, Office Of Health Economics

  • Past/current trends in parallel importing/exporting
  • Impact on the British public healthcare system
  • Future implications
  • 9:50 Critique of direct-to-pharmacy/reduced wholesaler models in Europe

  • Exclusive and supplementary direct-to-pharmacy distribution schemes in EU
  • Wholesaler rationalisation in EU
  • Case studies from UK, France, Germany and Poland
  • Manufacturers' aims, wholesalers and pharmacists response
  • What has been achieved?
  • Donald Macarthur

    Donald Macarthur, Global Pharmaceutical Business Analyst, JustPharmaReports

    10:30 Morning coffee

    11:00 Parallel trade: Solutions offered by competition law

    Axel Schulz

    Axel Schulz, Partner, White & Case LLP

  • Stock management systems, free pricing or direct-to-pharmacy?
  • Stock management systems in practice: issues such as measuring national demand, new entrants, allocations
  • Free pricing in practice: how to structure and set up the system.
  • Direct-to-pharmacy in practice: logistic service providers, tenders and emergency supplies
  • 11:40 The calm before the storm: Be prepared for the pharmaceutical package

    Jim Thomson

    Jim Thomson, Chair, European Alliance for Access to Safe Medicines

  • Where the legislation right now and what is the timeframe for implementation?
  • Why is it important to preserve as well as to strengthen the proposals?
  • The patient's role in making these proposals a success
  • 12:20 Networking lunch

    14:30 Parallel trade: A pharmacy contractor’s view

    Harry McQuillan

    Harry McQuillan, Chief Executive Officer, Community Pharmacy Scotland

  • Effect on the NHS
  • Availability of product
  • Effect on contractors’ income
  • Export vs. Import – the ethical debate
  • 15:10 Afternoon tea

    15:40 PANEL DISCUSSION - Does parallel trade generate worthwhile savings?

    Donald Macarthur

    Donald Macarthur, Global Pharmaceutical Business Analyst, JustPharmaReports

    Phill O'Neill

    Phill O'Neill, Consultant, Office Of Health Economics

    Harry McQuillan

    Harry McQuillan, Chief Executive Officer, Community Pharmacy Scotland

    16:20 Putting patient safety first

    Birgit Beger

    Birgit Beger, Secretary-General, Standing Committee of European Doctors (CPME)

  • Committing to patient safety
  • Combating counterfeit medicines
  • EU added value
  • Future outlook
  • 17:00 Chairman’s closing remarks and close of day one

    8:30 Re-registration and coffee

    9:00 Chairman's opening remarks

    David Hull

    David Hull, Partner, Covington & Burling

    9:10 Improvement of healthcare by banning repackaging of medicines by traders

    Dermot Glynn

    Dermot Glynn, Chairman, Europe Economics

  • The harm repackaging causes and how it leads to unsafe medicines
  • Effect on pricing
  • Unnecessary transportation costs
  • How it facilitates counterfeiting
  • Evidence needed from patent holders
  • Economic analysis needed from EU policymakers
  • 9:50 Parallel Trade: the third legitimate market player in Poland since 2005

    Tomasz Dzitko

    Tomasz Dzitko, Founder and CEO , Delfarma

  • The economics of parallel trade in Poland
  • Additional layer of safety in securing the integrity of distribution chain
  • There is no parallel trade without savings
  • The future of parallel trade in Poland from the importer's perspective
  • 10:30 Morning Coffee

    11:00 Parallel exports from the UK

    Tim Frazer

    Tim Frazer, EU and UK Competition Law Partner, Arnold & Porter LLP

  • Supply-chain design by UK pharmaceutical companies
  • The production of evidence of patient needs
  • The Intecare Direct vs. Pfizer judgment
  • The UK government’s approach to product shortage issues
  • 11:40 PANNEL DISCUSSION - Issues in competition law: theoretical and practical perspectives

    Janice Haigh

    Janice Haigh, Senior Director Europe Price & Trade, Astellas Pharma Europe

    Tim Frazer

    Tim Frazer, EU and UK Competition Law Partner, Arnold & Porter LLP

    12:20 Networking lunch

    13:50 The pharmaceutical industry’s response to parallel trade

    Fabrizio Gianfrate

    Fabrizio Gianfrate, Professor of Health Economics, University of Ferrara

  • Impact of Parallel Trade on Pharmaceutical Industry
  • The long term effects of parallel trade on R&D investments
  • The countermeasures of pharmaceutical industries
  • Evolution and next scenarios of strategies
  • 14:30 Economic evidence and standard of proof in the GSK and AstraZeneca cases

    Despoina Mantzari

    Despoina Mantzari, Research Fellow, Jevons Institute of Competition Law and Economics

  • Economic and empirical studies on the effect of parallel trade on consumers and sustainable development
  • European Court's approach to Parallel Trade
  • Reasons why the courts may not fully embrace the economists approach to parallel trade
  • 15:10 EU member states approach to parallel trade restrictions

    Héctor Armengod

    Héctor Armengod, Associate Attorney, Latham & Watkins LLP

  • Recent competition law developments at the Member State level
  • Reliance on guidance from the European Courts (General Court and the Court of Justice)
  • Divergent interpretations of the law
  • 15:50 Chairman’s closing remarks & Afternoon Tea



    Making Sense of Parallel Trade

    Making Sense of Parallel Trade

    Millennium Gloucester Hotel
    9th February 2011
    London, United Kingdom

    Millennium Gloucester Hotel

    Harrington Gardens
    London SW7 4LH
    United Kingdom

    Millennium Gloucester Hotel



    speaker image






    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.


    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.


    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.


    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title


    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event


    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71

    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SMi.
    Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out